Portfolio Optimization

Use The Relay Innovation Engine (RIE) to optimize your pipeline portfolio. The Relay Innovation Engine can help pharmaceutical and biotech companies explore and evaluate potential licensing and acquisition opportunities – from discovery and pre-clinical to the clinical stages of development. Build out a strong development pipeline by:

Identifying new licensing opportunities:

• Unearth new technologies that have high probability of success.
• Objectively evaluate and discover assets in your target category, including assets located outside of the US.

Assessing the relative attractiveness of assets under consideration:

Weigh how licensing and M&A transactions, and clinical development milestones impact the potential of your target asset.

Avoiding transactions that have limited potential:

Track your current targets performance against others in the category and over time.